Edwards Lifesciences's ticker is and the CUSIP is 26176E108. A total of 1 filers reported holding Edwards Lifesciences in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,061 | -58.8% | 21,847 | +36311.7% | 0.95% | +47400.0% |
| Q3 2022 | $5,000 | -28.6% | 60 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $7,000 | -12.5% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | +14.3% | 60 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | -22.2% | 60 | -45.5% | 0.00% | -25.0% |
| Q3 2020 | $9,000 | -10.0% | 110 | -26.7% | 0.00% | 0.0% |
| Q2 2020 | $10,000 | -16.7% | 150 | +200.0% | 0.00% | -20.0% |
| Q4 2019 | $12,000 | +33.3% | 50 | +25.0% | 0.01% | +25.0% |
| Q3 2019 | $9,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlphaMark Advisors, LLC | 60 | $8,000 | 0.00% |